Lumida
/ALIM
⌘K
Alimera Sciences Inc

Alimera Sciences Inc

ALIM
$5.54USD-0.18%-0.01 today

MARKET CAP

301.3M

P/E (TTM)

184.7x

FWD P/E

DAY RANGE

$6 – $6

52W RANGE

$3
$6
STATEMENT·Income statement
USD · GAAP
METRICFY 2019FY 2020FY 2021FY 2022FY 2023TREND
Sales, Adj.$53.9M$50.8M$59.0M$54.1M$80.8M
YoY %+15.8%-5.8%+16.2%-8.3%+49.2%
P / Sales
EV / Sales
Gross Profit, Adj.$47.3M$43.9M$52.0M$46.2M$69.9M
YoY %+11.9%-7.3%+18.5%-11.2%+51.5%
Margin %87.7%86.3%88.1%85.3%86.6%
EV / Gross Profit
EBITDA, Adj.$-2.6M$2.2M$2.4M$-8.9M$6.8M
YoY %+62.5%+182.6%+9.3%-475.7%+176.3%
Margin %-4.9%4.3%4.0%-16.5%8.4%
EV / EBITDA
EBIT$-5.3M$-501,000$-201,000$-11.6M$-1.9M
YoY %+45.5%+90.5%+59.9%-5691.0%+83.4%
Margin %-9.8%-1.0%-0.3%-21.5%-2.4%
EV / EBIT
Net Income$-10.4M$-5.3M$-4.4M$-18.1M$-21.4M
YoY %-147.6%+48.9%+18.1%-314.2%-18.1%
Net Margin-19.4%-10.5%-7.4%-33.5%-26.5%
EPS (GAAP)-$2.19-$1.04-$0.66-$2.59-$0.84
YoY %-159.0%+52.5%+36.5%-292.4%+67.6%